Van Leeuwen & Company’s Boston Scientific BSX Stock Holding History

Van Leeuwen & Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.91M	Sell	27,858 -1,023	-4%	-$65.8K	0.97%	44
2023 Q4	$1.67M	Buy	28,881 +497	+2%	+$26.5K	0.97%	46
2023 Q3	$1.5M	Buy	28,384 +706	+3%	+$37K	0.93%	38
2023 Q2	$1.48M	Sell	27,678 -306	-1%	-$16K	0.93%	33
2023 Q1	$1.4M	Buy	+27,984	New	+$1.32M	0.94%	33

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Van Leeuwen & Company's BSX Position: Q1 2024 in Review

Van Leeuwen & Company reduced its Boston Scientific (BSX) stake by 3.5% in Q1 2024, selling an estimated $65.8K and leaving 27,858 shares worth $1.91M. The position accounts for 0.97% of the portfolio, ranked #44.

Van Leeuwen & Company first reported a position in BSX in Q1 2023 and has held it in 5 quarters since. 1,223 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

Van Leeuwen & Company held 27,858 shares of Boston Scientific worth $1.91M as of Q1 2024.
Van Leeuwen & Company sold 1,023 Boston Scientific shares in Q1 2024, an estimated $65.8K.
Boston Scientific made up 0.97% of Van Leeuwen & Company's portfolio in Q1 2024, its #44 holding.
Van Leeuwen & Company first reported a position in Boston Scientific in Q1 2023 and has held it in 5 quarters since.
1,223 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Van Leeuwen & Company's 13F filing for Q1 2024, filed 10 May 2024.